Bangalore, India, 560085
This combination tablet of Voglibose 0.2mg, Glimepiride 2mg, and Metformin HCL 1000mg is an advanced antidiabetic therapy designed to manage type 2 diabetes mellitus effectively. Voglibose works by inhibiting intestinal enzymes (alpha-glucosidase), delaying carbohydrate absorption, and reducing post-meal blood sugar spikes. Glimepiride is a sulfonylurea that stimulates insulin secretion from pancreatic beta cells, helping in better glucose utilization. Metformin HCL improves insulin sensitivity, reduces hepatic glucose production, and promotes better glucose uptake in muscles. This triple-action formula helps maintain optimal glycemic control, reduces the risk of diabetes-related complications, and supports overall metabolic health. It is suitable for patients who require combination therapy to achieve target blood glucose levels.